|
Name |
5-Chloroisorotiorin
|
Molecular Formula | C23H23ClO5 | |
IUPAC Name* |
(6aR)-9-acetyl-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-6a-methylfuro[2,3-h]isochromene-6,8-dione
|
|
SMILES |
CC[C@H](C)/C=C(\C)/C=C/C1=CC2=C(C(=O)[C@]3(C(=C(C(=O)O3)C(=O)C)C2=CO1)C)Cl
|
|
InChI |
InChI=1S/C23H23ClO5/c1-6-12(2)9-13(3)7-8-15-10-16-17(11-28-15)19-18(14(4)25)22(27)29-23(19,5)21(26)20(16)24/h7-12H,6H2,1-5H3/b8-7+,13-9+/t12-,23+/m0/s1
|
|
InChIKey |
QJSWSNAZIVGTFZ-UNSJDTSZSA-N
|
|
Synonyms |
5-Chloroisorotiorin; Isochlororotiorin; (+)-5-Chloroisorotiorin; AFB4KX29XT; 27527-41-9; 6H-Furo(2,3-H)-2-benzopyran-6,8(6ah)-dione, 9-acetyl-5-chloro-3-((1E,3E,5S)-3,5-dimethyl-1,3-heptadienyl)-6a-methyl-, (6aR)-; 6H-Furo(2,3-H)-2-benzopyran-6,8(6ah)-dione, 9-acetyl-5-chloro-3-(3,5-dimethyl-1,3-heptadienyl)-6a-methyl-, (R-(R*,S*-(E,E)))-; UNII-AFB4KX29XT; CHEMBL4291005; (6aR)-3-[(1E,3E,5S)-3,5-Dimethyl-1,3-heptadienyl]-5-chloro-6abeta-methyl-9-acetyl-6H-furo[2,3-h]-2-benzopyran-6,8(6aH)-dione
|
|
CAS | 27527-41-9 | |
PubChem CID | 10364495 | |
ChEMBL ID | CHEMBL4291005 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 414.9 | ALogp: | 4.3 |
HBD: | 0 | HBA: | 5 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 69.7 | Aromatic Rings: | 3 |
Heavy Atoms: | 29 | QED Weighted: | 0.357 |
Caco-2 Permeability: | -4.788 | MDCK Permeability: | 0.00001820 |
Pgp-inhibitor: | 0.733 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.015 | 20% Bioavailability (F20%): | 0.075 |
30% Bioavailability (F30%): | 0.072 |
Blood-Brain-Barrier Penetration (BBB): | 0.03 | Plasma Protein Binding (PPB): | 88.18% |
Volume Distribution (VD): | 2.167 | Fu: | 7.64% |
CYP1A2-inhibitor: | 0.938 | CYP1A2-substrate: | 0.843 |
CYP2C19-inhibitor: | 0.962 | CYP2C19-substrate: | 0.289 |
CYP2C9-inhibitor: | 0.943 | CYP2C9-substrate: | 0.088 |
CYP2D6-inhibitor: | 0.929 | CYP2D6-substrate: | 0.039 |
CYP3A4-inhibitor: | 0.96 | CYP3A4-substrate: | 0.486 |
Clearance (CL): | 1.49 | Half-life (T1/2): | 0.451 |
hERG Blockers: | 0.008 | Human Hepatotoxicity (H-HT): | 0.926 |
Drug-inuced Liver Injury (DILI): | 0.98 | AMES Toxicity: | 0.811 |
Rat Oral Acute Toxicity: | 0.876 | Maximum Recommended Daily Dose: | 0.946 |
Skin Sensitization: | 0.932 | Carcinogencity: | 0.958 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.048 |
Respiratory Toxicity: | 0.938 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002525 | 0.733 | D0B1IP | 0.213 | ||||
ENC005420 | 0.708 | D0C1SF | 0.212 | ||||
ENC001841 | 0.685 | D0WY9N | 0.212 | ||||
ENC001874 | 0.663 | D05QDC | 0.203 | ||||
ENC002178 | 0.579 | D0O6KE | 0.202 | ||||
ENC001876 | 0.543 | D0G3PI | 0.191 | ||||
ENC004761 | 0.533 | D02DGU | 0.191 | ||||
ENC003626 | 0.496 | D00DKK | 0.191 | ||||
ENC004762 | 0.496 | D02GAC | 0.189 | ||||
ENC001870 | 0.491 | D0R6RC | 0.188 |